Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063365274> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2063365274 endingPage "1328" @default.
- W2063365274 startingPage "1323" @default.
- W2063365274 abstract "Abstract Purpose To determine the maximum‐tolerated dose, dose‐limiting toxicities, and pharmacokinetics of the kinesin spindle protein inhibitor ispinesib in pediatric patients with recurrent or refractory solid tumors. Subjects and Methods Ispinesib was administered as 1‐hr intravenous infusion weekly × 3, every 28 days. Cohorts of 3–6 patients were enrolled at 5, 7, 9, and 12 mg/m 2 /dose. Serial plasma samples for pharmacokinetic analyses were obtained after the first dose. Results Twenty‐four (13 females) patients with a median (range) age of 10 years (1–19) were enrolled in the study. At the 12 mg/m 2 dose level dose‐limiting neutropenia occurred in 2/6 patients and hyperbilirubinemia in 1/6 patients, while at the 9 mg/m 2 dose level 1/6 patients had dose‐limiting neutropenia. There were no objective responses, but three patients (diagnoses of anaplastic astrocytoma, alveolar soft part sarcoma, and ependymoblastoma) had stable disease for 4–7 courses. There was substantial interpatient variation in drug disposition. The median (range) terminal elimination half‐life was 16 (8–44) hr and the plasma drug clearance was 5 (1–14) L/hr/m 2 . Conclusions The maximum tolerated and recommended phase II dose for ispinesib administered weekly × 3 every 28 days for children with solid tumors is 9 mg/m 2 /dose. Plans for a phase II trial in select pediatric solid tumors are in development. Pediatr Blood Cancer. 2010;55:1323–1328. © 2010 Wiley‐Liss, Inc." @default.
- W2063365274 created "2016-06-24" @default.
- W2063365274 creator A5021851526 @default.
- W2063365274 creator A5023130316 @default.
- W2063365274 creator A5027468886 @default.
- W2063365274 creator A5035201571 @default.
- W2063365274 creator A5037980313 @default.
- W2063365274 creator A5038563211 @default.
- W2063365274 creator A5066484657 @default.
- W2063365274 date "2010-08-13" @default.
- W2063365274 modified "2023-10-10" @default.
- W2063365274 title "A pediatric phase I trial and pharmacokinetic study of ispinesib: A Children's Oncology Group phase I consortium study" @default.
- W2063365274 cites W1571073982 @default.
- W2063365274 cites W1988678729 @default.
- W2063365274 cites W1997853067 @default.
- W2063365274 cites W2004109623 @default.
- W2063365274 cites W2014952173 @default.
- W2063365274 cites W2033480577 @default.
- W2063365274 cites W2035826479 @default.
- W2063365274 cites W2052453216 @default.
- W2063365274 cites W2075277027 @default.
- W2063365274 cites W2078967650 @default.
- W2063365274 cites W2081181781 @default.
- W2063365274 cites W2108489838 @default.
- W2063365274 cites W2139248078 @default.
- W2063365274 cites W2146314877 @default.
- W2063365274 cites W2160059044 @default.
- W2063365274 cites W2162311389 @default.
- W2063365274 doi "https://doi.org/10.1002/pbc.22609" @default.
- W2063365274 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3053384" @default.
- W2063365274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20712019" @default.
- W2063365274 hasPublicationYear "2010" @default.
- W2063365274 type Work @default.
- W2063365274 sameAs 2063365274 @default.
- W2063365274 citedByCount "38" @default.
- W2063365274 countsByYear W20633652742012 @default.
- W2063365274 countsByYear W20633652742013 @default.
- W2063365274 countsByYear W20633652742014 @default.
- W2063365274 countsByYear W20633652742015 @default.
- W2063365274 countsByYear W20633652742016 @default.
- W2063365274 countsByYear W20633652742017 @default.
- W2063365274 countsByYear W20633652742019 @default.
- W2063365274 countsByYear W20633652742020 @default.
- W2063365274 countsByYear W20633652742021 @default.
- W2063365274 countsByYear W20633652742022 @default.
- W2063365274 crossrefType "journal-article" @default.
- W2063365274 hasAuthorship W2063365274A5021851526 @default.
- W2063365274 hasAuthorship W2063365274A5023130316 @default.
- W2063365274 hasAuthorship W2063365274A5027468886 @default.
- W2063365274 hasAuthorship W2063365274A5035201571 @default.
- W2063365274 hasAuthorship W2063365274A5037980313 @default.
- W2063365274 hasAuthorship W2063365274A5038563211 @default.
- W2063365274 hasAuthorship W2063365274A5066484657 @default.
- W2063365274 hasBestOaLocation W20633652742 @default.
- W2063365274 hasConcept C112705442 @default.
- W2063365274 hasConcept C121332964 @default.
- W2063365274 hasConcept C126322002 @default.
- W2063365274 hasConcept C142424586 @default.
- W2063365274 hasConcept C2776694085 @default.
- W2063365274 hasConcept C2777063308 @default.
- W2063365274 hasConcept C2777288759 @default.
- W2063365274 hasConcept C71924100 @default.
- W2063365274 hasConcept C87355193 @default.
- W2063365274 hasConcept C90924648 @default.
- W2063365274 hasConceptScore W2063365274C112705442 @default.
- W2063365274 hasConceptScore W2063365274C121332964 @default.
- W2063365274 hasConceptScore W2063365274C126322002 @default.
- W2063365274 hasConceptScore W2063365274C142424586 @default.
- W2063365274 hasConceptScore W2063365274C2776694085 @default.
- W2063365274 hasConceptScore W2063365274C2777063308 @default.
- W2063365274 hasConceptScore W2063365274C2777288759 @default.
- W2063365274 hasConceptScore W2063365274C71924100 @default.
- W2063365274 hasConceptScore W2063365274C87355193 @default.
- W2063365274 hasConceptScore W2063365274C90924648 @default.
- W2063365274 hasIssue "7" @default.
- W2063365274 hasLocation W20633652741 @default.
- W2063365274 hasLocation W20633652742 @default.
- W2063365274 hasLocation W20633652743 @default.
- W2063365274 hasLocation W20633652744 @default.
- W2063365274 hasOpenAccess W2063365274 @default.
- W2063365274 hasPrimaryLocation W20633652741 @default.
- W2063365274 hasRelatedWork W1971885716 @default.
- W2063365274 hasRelatedWork W1992426253 @default.
- W2063365274 hasRelatedWork W2151922639 @default.
- W2063365274 hasRelatedWork W2159406923 @default.
- W2063365274 hasRelatedWork W2911677179 @default.
- W2063365274 hasRelatedWork W2915644342 @default.
- W2063365274 hasRelatedWork W3034286462 @default.
- W2063365274 hasRelatedWork W3166797618 @default.
- W2063365274 hasRelatedWork W4210913627 @default.
- W2063365274 hasRelatedWork W4288738052 @default.
- W2063365274 hasVolume "55" @default.
- W2063365274 isParatext "false" @default.
- W2063365274 isRetracted "false" @default.
- W2063365274 magId "2063365274" @default.
- W2063365274 workType "article" @default.